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The Drosophila Cytosine-5 Methyltransferase Dnmt2 Is
Associated with the Nuclear Matrix and Can Access DNA
during Mitosis
Matthias Schaefer, Julia P. Steringer, Frank Lyko*
Division of Epigenetics, Deutsches Krebsforschungszentrum, Heidelberg, Germany
Cytosine-5 methyltransferases of the Dnmt2 family are highly conserved in evolution and their biological function is being
studied in several organisms. Although all structural DNA methyltransferase motifs are present in Dnmt2, these enzymes show
a strong tRNA methyltransferase activity. In line with an enzymatic activity towards substrates other than DNA, Dnmt2 has
been described to localize to the cytoplasm. Using molecular and biochemical approaches we show here that Dnmt2 is both a
cytoplasmic and a nuclear protein. Sub-cellular fractionation shows that a significant amount of Dnmt2 is bound to the nuclear
matrix. Sub-cellular localization analysis reveals that Dnmt2 proteins are enriched in actively dividing cells. Dnmt2 localization
is highly dynamic during the cell cycle. Using live imaging we observed that Dnmt2-EGFP enters prophase nuclei and shows a
spindle-like localization pattern during mitotic divisions. Additional experiments suggest that this localization is microtubule
dependent and that Dnmt2 can access DNA during mitotic cell divisions. Our results represent the first comprehensive
characterization of Dnmt2 proteins on the cellular level and have important implications for our understanding of the
molecular activities of Dnmt2.
Citation: Schaefer M, Steringer JP, Lyko F (2008) The Drosophila Cytosine-5 Methyltransferase Dnmt2 Is Associated with the Nuclear Matrix and Can
Access DNA during Mitosis. PLoS ONE 3(1): e1414. doi:10.1371/journal.pone.0001414
INTRODUCTION
The methylation of cytosine residues plays an important role in the
regulation of nucleic acids. Cytosine-5 RNA methylation is one
among many different RNA modifications and has been detected
in tRNA, rRNA and mRNA [1]. Cytosine-5 DNA methylation
represents an important epigenetic modification regulating gene
expression in eukaryotes and has been shown to be important
during development and for the etiology of human disease [2,3].
Elucidating the molecular mechanisms mediating RNA and DNA
methylation is crucial to understand the roles that diverse nucleic
acids play in the regulation of genetic information.
Based on the conservation of catalytic cytosine-5 DNA
methyltransferase motifs, Dnmt2 has been assigned to the DNA
methyltransferase enzyme family [4,5]. Dnmt2 proteins have been
widely conserved during evolution and their protein structure
closely resembles that of known cytosine-5 DNA methyltransfer-
ases [6]. While initial studies failed to detect an enzymatic activity
for Dnmt2, more recent reports have provided evidence for a low
but significant DNA methyltransferase activity for human [7],
Drosophila [8], Entamoeba [9] and Dictyostelium [10] Dnmt2. In
addition, it has also been shown that Dnmt2 from various
organisms methylates cytosine 38 in the anticodon loop of
tRNA
Asp [11]. These data raised the possibility that the substrate
specificity of Dnmt2 enzymes might be broader than previously
anticipated [12].
Expression analyses of Dnmt2 in various model systems have
suggested that Dnmt2 might be developmentally and tissue-
specifically regulated. For example, human and mouse Dnmt2
have been shown to be expressed at relatively high levels in the
heart, lung, kidney and testis [4,5]. In addition, Dnmt2 expression
has been shown to be elevated during early developmental stages
in Drosophila and in zebrafish [8,13,14], which suggested a
developmental role of the protein. In agreement with this notion,
Dnmt2 mutant zebrafish showed defective liver, brain and retina
development [15]. Understanding the significance of this pheno-
type, will require further investigation, because Dnmt2 mutant
mice, flies and plants (Arabidopsis thaliana) have been described to be
viable and fertile [11]. The limited understanding of the cellular
characteristics of Dnmt2 has so far precluded a detailed analysis of
Dnmt2 mutant organisms.
Because of their annotation as DNA methyltransferases, Dnmt2
enzymes have been expected to be nuclear proteins. However,
ectopically expressed human Dnmt2 has been shown to localize in
the cytoplasm of transiently transfected cells [11], which is in
contrast to the nuclear localization of established DNA methyl-
transferases [16], and has been interpreted to be in agreement with
the tRNA methyltransferase activity of the protein [11]. However,
this observation cannot provide an explanation for the observed
DNA methyltransferase activity of Dnmt2. In addition, a Dnmt2
homologue in Dictyostelium has been shown to reside in the
nucleus [10] and a Dnmt2 homologue in Entamoeba has been
associated with the nuclear matrix [17]. These observations are
difficult to reconcile with the conclusion that Dnmt2 is exclusively
cytoplasmic [11].
Because the identification of sub-cellular compartments associ-
ated with individual proteins is important for understanding their
molecular activities, a systematic analysis of the sub-cellular
localization of Dnmt2 should provide valuable information to
define the function of these enzymes. In order to characterize
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to biochemically trace Dnmt2 as well as fusion proteins to EGFP
and GAL4:VP16, that allowed us to study the sub-cellular
dynamics and localization of Dnmt2. We show that Dnmt2 is
also a nuclear protein, which is part of the insoluble nuclear
matrix. Dnmt2-EGFP could be predominantly visualized in endo-
replicating and dividing nuclei. These findings show that the sub-
cellular distribution of Dnmt2 is fundamentally different from that
of other DNA or tRNA methyltransferases and provide experi-
mental support for the notion that Dnmt2 enzymes have multiple
molecular activities.
RESULTS
Expression of Dnmt2 during Drosophila
development
As an initial step towards the characterization of Dnmt2, we affinity
purified antibodies against a peptide epitope encompassing amino
acids 78–93 of the annotated protein (Mt2-PA, Genebank accession
no. AAF53163) (Fig. 1A). These antibodies recognize Dnmt2 as a
40 kDa protein on Western blots and can efficiently immunopre-
cipitate Dnmt2 from protein extracts, as confirmed by mass-
spectrometry (Fig. 1B and data not shown). The 40 kDa
polypeptide was not recognized in protein extracts from a
homozygous Dnmt2 mutant strain [11]. The introduction of a
genomic Dnmt2 transgene (pGeno-Dnmt2) into the Dnmt2 mutant
background via P-element mediatedgermline transformationled to
the re-expression of the 40 kDa polypeptide (Fig. 1C). The available
experimental data indicates that Dnmt2 can methylate both DNA
and tRNA. This suggests that the protein should be detectable not
only in the cytoplasm but also in nuclei. We therefore biochemically
fractionated 0–6 hours old wildtype embryos to obtain cytoplasmic
and nuclear protein extracts and found that the majority of Dnmt2
protein is cytoplasmic. However, purified nuclei contained a
significant amount of Dnmt2 (Fig.1D). Furthermore, testingprotein
extracts of wildtype animals of various developmental stages we
observed that Dnmt2 is expressed throughout development and in
adults. (Fig. 1E). We concluded that Dnmt2 is present during all
stages of Drosophila development and that a fraction of cellular
Dnmt2 resides in nuclei.
Figure 1. Establishment of Dnmt2-specific antibodies and characterization of Dnmt2 expression during Drosophila development. (A) Sequence
of the epitope recognized by polyclonal antibodies against Dnmt2 peptide spanning amino acids 78–93. (B) Affinity-purified anti-Dnmt2 antibodies
efficiently immunoprecipitate Dnmt2 from whole cell protein extracts. (C) Anti-Dnmt2 specifically detects a 40 kDa protein. Whole-cell protein
extracts from wildtype, homozygous mutants (Dnmt2D) and rescued mutants (pGenoDnmt2) were blotted and probed with anti-Dnmt2. (D) Early
embryonic tissue (0–6 hr AEL) was fractionated, blotted as cytoplasmic and nuclear fractions and probed with anti-Dnmt2 and anti-^-tubulin as
control. (E) Developmental Western blot. Wildtype cytoplasmic protein extract from various embryonic, larval and adult stages were blotted and
probed with anti-Dnmt2. Ponceau staining of blot is shown as loading control. hc-heavy chain, cytopl.-cytoplasmic, nucl.-nuclear, E-embryo, L1-first
instar larvae, L2-second instar larvae, L3-third instar larvae, A-adult, f-female, m-males.
doi:10.1371/journal.pone.0001414.g001
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embryogenesis and in the adult germ line
Since Dnmt2 expression could be detected during all stages of
Drosophila development we asked whether Dnmt2 displays a tissue-
specific expression. Our affinity purified antibodies against Dnmt2
were not suitable for indirect immunofluoresence experiments,
which was most likely due to epitope masking (data not shown). We
therefore created several independent transgenic fly lines harbour-
ing a Dnmt2-EGFP fusion gene in the genomic sequence context of
the Dnmt2 locus (pGeno-Dnmt2-EGFP). Since Dnmt2 mutant
animals areviable andfertileand do notdisplay obvious phenotypes
we could not positively test whether the genomic Dnmt2-EGFP
contstruct is functional. On the other hand, co-immunoprecipita-
tion experiments using both endogenous Dnmt2 as well as Dnmt2-
EGFP constructs revealed that Dnmt2-EGFP is contained in similar
protein complexes, suggesting that part of the functionality of
Dnmt2 is retained in the fusion protein (unpublished observations).
In order to test whether these constructs express tagged Dnmt2
similarly to endogenous Dnmt2 we performed Western blot analysis
of protein extracts from various developmental stages and adult
tissues using antibodies against Dnmt2. We found that Dnmt2-
EGFP was expressed during all stages of development and at levels
that were comparable with those of the endogenous Dnmt2 protein
(Fig. 2A). Furthermore, biochemical fractionation of embryonic
protein extracts and immunolocalization of Dnmt2-EGFP in
salivary glands showed that the fusion protein could be imported
into nuclei, suggesting that the sub-cellular localization signals were
functionally retained (Fig. 2A and C).
To further validate the expression of the pGeno-Dnmt2-EGFP
construct we stained embryos and adult tissue using anti-EGFP
antibodies. We found that the construct was ubiquitously
expressed during early embryogenesis. Expression remained
ubiquitous throughout development with enrichment in the fore-
and hindgut as well as in the developing mesoderm in gastrulating
embryos (Fig. 2B). This expression pattern strongly coincided with
the published pattern of the endogenous Dnmt2 transcript [14],
which further indicated that the pGeno-Dnmt2-EGFP construct
mirrors the endogenous expression pattern of Dnmt2 transcripts.
Figure 2. Tissue specific expression of Dnmt2. (A) Left panel: developmental Western blot of pGeno-Dnmt2-EGFP animals. Whole protein extract
from embryonic, larval and adult stages were blotted and probed with anti-Dnmt2. Ponceau staining is shown as a loading control. Right panel:
Dnmt2-EGFP is expressed both in the cytoplasm and in nuclei. Fractionation efficiency was confirmed by probing the blot for cytoplasmic ^-tubulin
and nuclear Lamin C. Antibodies against EGFP reveal Dnmt2 in developing embryos (B), third instar larval salivary glands (C), ovaries (D) and testes (E).
(F) Dnmt2-EGFP in a developing cyst of the female germline is mostly cytoplasmic. Nuclear staining can be observed in nurse cell nuclei. (G) Dnmt2-
EGFP in the male germline is ubiquitous in all cells with the exception of somatic hub cells (marked by Armadillo, red). Scale bars: (B) 100 mm; (C)
10 mm; (D) 50 mm; (E) 100 mm; (F) 20 mm; (G) 10 mm.
doi:10.1371/journal.pone.0001414.g002
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(Fig. 1D) we determined the cellular Dnmt2-EGFP protein
expression pattern during gametogenesis using anti-EGFP antibod-
ies. We found that Dnmt2-EGFP is highly expressed in the
germarium, blastocyst and cyst stages of the female germ line with
the noticeable exception of follicle cells (Fig. 2D). Dnmt2-EGFP was
mostly present in the cytoplasm but could also be found in nurse cell
nuclei (Fig. 2D, F). In the male germ line, Dnmt2-EGFP was
expressed in most cells, including stem cells as well as in maturing
spermatocytes (Fig. 2E) with the exception of the post-mitotic hub
cells (Fig. 2G). Dnmt2-EGFP protein was mostly cytoplasmic and
mature sperm did not show any Dnmt2-EGFP signal above
background (data not shown). From these observations we
concluded that Dnmt2-EGFP is expressed in DNA-synthesizing
tissues such as endo-replicating nurse and salivary gland cells as well
as in the proliferating regions of the adult germ line.
A significant fraction of Dnmt2 localizes to nuclei
Since a fraction of Dnmt2 could be purified with intact nuclei we
asked whether this nuclear localization could be developmentally
regulated. Western blots of purified nuclei show that a significant
amount of Dnmt2 protein can be recovered in all developmental
stages analyzed (Fig. 3A). Nuclear Dnmt2 protein levels appeared
to be comparably elevated in young (E 0-3, E 3-6) embryos and in
ovaries (Fig. 3A).
Because tRNA modifications have been reported to occur in
nucleoli [18,19], we sought to identify the sub-nuclear structures
associated with Dnmt2. As a first step, we tested whether Dnmt2
co-fractionates with nucleoli. After disruption of purified nuclei
and density fractionation through sucrose cushions we separated
nucleoli from the rest of the nuclear structures. Tracing nucleolar
material using an antibody against fibrillarin we found that Dnmt2
was not enriched in nucleoli (Fig. 3B). Using micrococcal nuclease
(MNase) digestion of purified nuclei to release histone-associated
chromatin, we observed that nuclear Dnmt2 is not solubilized,
suggesting that Dnmt2 is not chromatin-bound. While canonical
histones such as histone H3 were released from MNase and EDTA
treated nuclei, Dnmt2 remained in the nuclear remnants (Fig. 3C).
To determine whether the nuclear Dnmt2 fraction is associated
with the nuclear matrix we salt extracted purified nuclei. For
controls we used antibodies against the insulator protein CP-190,
which is peripherally associated with the nuclear matrix, as well as
antibodies against Lamin C that is an integral part of the nuclear
matrix. These experiments showed that most of the nuclear
Dnmt2 protein remains insoluble after extraction. In order to
analyze nuclear Dnmt2, salt-extracted nuclei had to be treated
with 7 M urea to solubilize the protein (Fig. 3D). We concluded
that nuclear Dnmt2 is not available as a soluble protein in the
nucleoplasm but is part of insoluble structures, such as the nuclear
matrix.
Figure 3. Dnmt2 is present in nuclei and resides in an insoluble part of the nuclear matrix. (A) Developmental Western blot. Purified nuclei from
embryonic and adult tissues were urea extracted, blotted and probed with anti-Dnmt2. Ponceau staining is shown as a loading control, lamin C
staining is shown as a control for the enrichment of nuclear proteins. (B) Dnmt2 is not enriched in nucleoli. Sucrose density fractionation of nucleoli
followed by blotting and tracing of nucleolar material using anti-Fibrillarin shows that Dnmt2 is part of other nuclear structures. (C) Dnmt2 is not
enriched in nucleosomes. Micrococcal nuclease digest of purified nuclei releases histone H3 (EDTA supernatant), but not Dnmt2. The EDTA extracted
nuclei still contain Dnmt2 suggesting association of Dnmt2 with non-chromatin structures. (D) Dnmt2 is associated with the nuclear matrix. Nuclear
Dnmt2 is insoluble after DNAse digest, followed by high salt extraction and can only be solublilzed using urea extraction. CP-190 is included as a
peripheral and lamin C as an integral nuclear matrix interacting protein. E-embryo, A-adult, f-female, m-males, MNase-micrococcal nuclease, sup-
supernatant.
doi:10.1371/journal.pone.0001414.g003
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Dnmt2 can reside both in nuclei and in the cytoplasm, which suggests
that the protein is shuttling between these compartments. We therefore
sought to characterize the dynamic aspects of Dnmt2 localization.
However, the comparably low expression levels of the genomic
Dnmt2-EGFP reporter construct precluded the direct visualization of
Dnmt2-EGFP in embryos. Additionally, yolk autofluorescence did not
allow for high resolution imaging in embryonic tissues. We therefore
determined the localization of Dnmt2-EGFP using anti-EGFP
antibodies in fixed cleavage stage embryos and found that Dnmt2-
EGFP accumulated around nuclear structures at the beginning of M-
phase during the nuclear division cycles. This protein localization
persisted into anaphase, when Dnmt2-EGFP became concentrated at
structures between daughter nuclei and returned to become
cytoplasmic at the time of karyokinesis (Fig. 4A).
We next determined whether Dnmt2 localizes to mitotic nuclei
in developmental stages beyond the syncitial cleavage divisions.
Ectopic expression of Dnmt2 during later developmental stages
using both ubiquitous (hs-GAL4, data not shown) and cell-specific
promoters driving GAL4 (asense-GAL4) in flies carrying a UAS-
Dnmt2-EGFP transgene we observed that the Dnmt2 fusion
protein also accumulated around chromosomes in mitotic cells,
such as in neuroblasts in the embryonic neuroectoderm (Fig. 4B).
In contrast, actin5C driven UAS-EGFP protein showed a diffuse
cytoplasmic localization under the same experimental conditions
(Fig. S1) suggesting that the Dnmt2 mojety targets the EGFP signal
to mitotic chromatin.
In order to further analyze the mitotic localization of Dnmt2 we
used the developing larval brain, which contains a high number of
proliferating neuroblasts giving rise to ganglion mother cells
(GMC). Analyzing third instar larval brains of animals expressing
pGeno-Dnmt2-EGFP (Fig. 4C, D) we found EGFP positive cells
marking dividing neuroblasts whereas Dnmt2-EGFP was absent
from GMC that were identified by staining for the transcription
factor Prospero (Fig. 4E). From these results we concluded that
Dnmt2 is enriched in mitotic but not in post-mitotic cells, which
suggests a role of Dnmt2 in actively cycling cells.
Dnmt2 is dynamically localizing to mitotic nuclei
To study the localization of Dnmt2 in living tissue we used
transgenic flies expressing a Dnmt2-EGFP fusion protein under
the control of the ubiquitin promoter (pUbq-Dnmt2-EGFP). This
allowed for sufficiently high levels of Dnmt2-EGFP in early
embryos and overcame the technical problems described previ-
ously. To follow nuclear divisions we crossed Dnmt2-EGFP
expressing flies with animals expressing the histone H2A variant
fused to red fluorescent protein (His2Av-mRFP1) which served as
a chromatin marker.
Imaging Dnmt2-EGFP through consecutive cleavage cycles
revealed that the fusion protein is distributed diffusely during S-
Figure 4. Dnmt2 localizes to mitotically active cells. (A) pGeno-Dnmt2-EGFP localizes to mitotic nuclei during prophase and localizes to midbody
structures in telophase as visualized by anti-EGFP staining. Pictures show the distribution of Dnmt2-EGFP (gray, upper panel) and merged images
(lower panel) with Dnmt2-EGFP in green and DNA in red. (B) Ectopic Dnmt2-EGFP localizes around metaphase chromosomes. Cell-type specific
expression of UAS-Dnmt2-EGFP using asense-GAL4 causes Dnmt2 to localize to nuclear structures during mitosis. Ectopic protein localizes to
prophase chromatin of CNS neuroblasts (upper panel) and aggregates densely around the mitotic metaphase plate (lower panel). (C) pGeno-Dnmt2-
EGFP localizes to mitotic nuclei during larval development (upper panel). Frequently dividing optic lobe neuroblasts are enriched for Dnmt2-EGFP
expression as visualized by anti-EGFP staining (lower panel). (D–E) Ventral ganglion neuroblasts express high levels of Dnmt2-EGFP, whereas ganglion
mother cells (marked by Prospero, red, in E), which give rise to differentiated neurons and glia, do not express Dnmt2-EGFP. Scale bars: (A) 10 mm; (B)
10 mm; (C, D) 50 mm; (E, F) 20 mm; (G) 10 mm.
doi:10.1371/journal.pone.0001414.g004
Dnmt2, Mitosis, Nuclear Matrix
PLoS ONE | www.plosone.org 5 January 2008 | Issue 1 | e1414phase but rapidly localizes to prophase nuclei at the onset of
mitosis. During meta- and anaphase Dnmt2-EGFP formed
spindle-like structures and re-localized to midbody structures
during karyokinesis. During the following S-phase Dnmt2-EGFP
was diffusely distributed throughout the syncitial cytoplasm until
the start of the next mitotic phase. (Fig. 5A and movie S1).
The mitotic localization of Dnmt2 was reminiscent of
microtubule (MT) structures that form the spindle apparatus
during cell divisions. We co-stained embryos for Dnmt2-EGFP
and tubulin and found that the signals overlap only partially
(Fig. 5B-left panel). In order to test whether Dnmt2-EGFP
localization depends on the presence of intact MTs we treated
embryos with colcemide to destabilize MTs. We found that the
spindle-like Dnmt2-EGFP localization in mitotic nuclei was lost
(Fig. 5B-middle panel). Stabilization of MTs using taxol caused a
more diffuse localization of Dnmt2-EGFP around mitotic
chromosomes (Fig. 5B-right panel) but did not trigger the re-
localization of Dnmt2-EGFP to ectopic microtubule-rich regions,
indicating an indirect interaction between Dnmt2-EGFP and
MTs. We concluded that the syncitial pool of Dnmt2-EGFP is
dynamically changing from a uniformly cytoplasmic localization
during S-phase to a microtubule-dependent spindle-like distribu-
tion during pro- and metaphase of mitosis.
The dynamic localization of Dnmt2 to mitotic chromosomes
raised the possibility that Dnmt2 could transiently access DNA
during this particular phase of the cell cycle. In order to test
whether Dnmt2 is interacting with DNA we used a chimeric
transcription factor GAL4:VP16 (GV) fused to Dnmt2. The
GAL4-VP16 protein contains the DNA-binding domain of the
yeast transcription factor GAL4 linked to the transcriptional
activating domain of the viral VP16 protein [20]. This reporter
system has been used previously to characterize the nuclear access
of the Notch intracellular domain [21] and was therefore be
adapted to trace the nuclear access of GV-Dnmt2 (Fig. 6A, B).
Because overexpression of GAL4-VP16 alone is cytotoxic to cells
(G. Struhl, personal communication) we also established a control
construct where the GAL4-VP16 domain was embedded in a split
Dnmt2 protein (Fig. 6B). The resulting GV-Dnmt2 proteins were
ubiquitously expressed in animals also carrying a UAS-EGFP
transgene. Expression of GV-Dnmt2 from the polyubiquitin
promotor in embryos showed ubiquitously high levels of UAS-
EGFP (data not shown). We therefore focused our analysis on
larval imaginal disc tissues that develop more slowly and contain
cycling and differentiating cells. In the larval brain we observed
transactivation of the EGFP reporter in many cells interspersed by
cells not displaying EGFP signal (Fig. 6C). This pattern was
reminiscent of the expression pattern of Dnmt2-EGFP expressed
from the genomic construct (Fig. 4D,E) suggesting that cycling
neuroblasts allow access of the transactivator fusion protein to
DNA. In order to directly examine the possibility that mitotic cells
allow access of Dnmt2 to DNA we analyzed third instar larval eye
discs. These tissues undergo a well-characterized differentiation
process after a mitotic wave of cell divisions (morphogenetic
furrow). Even though both Dnmt2 fusion proteins were expressed
ubiquitously across the eye discs (Fig. 6D,E-GAL4 panel), we
observed that GAL4-VP16 access to DNA occured only with the
GV-Dnmt2 construct, as evidenced by a strong EGFP expression
in the differentiating photoreceptor cells (Fig. 6D). The control
construct showed only weak and patchy activation of the UAS-
EGFP reporter behind the morphogenetic furrow reflecting the
stochastic background access of GAL4-VP16 to DNA (Fig. 6E).
These experiments suggest that Dnmt2 can access DNA in cells
Figure 5. Dnmt2 localization to mitotic nuclei is dynamic and microtubuli-dependent. (A) Nuclear division cycle 10 embryos expressing pUbq-
Dnmt2-EGFP and His2Av-mRFP1 were mounted on an open coverslip and viewed by dual wavelength time-lapse LSCM. Selected frames are shown
for Dnmt2-EGFP (gray, upper panel) and as merged images (lower panel) with Dnmt2-EGFP in green and His2A-mRFP1 in red. A movie of the
sequence is available as supporting material. (B) 1–3 h old embryos expressing pGeno-Dnmt2-EGFP were collected and fixed immediately (left panel),
treated with colcemide (middle panel) or with taxol (right panel) in order to disrupt or stabilize microtubuli, respectively. Metaphase chromosomes
are shown with Dnmt2 (gray), DNA (red) and ^-tubulin (green). While Dnmt2-EGFP is maintained around metaphase plates in taxol-treated embryos,
the protein is delocalized in colcemide-treated embryos. Scale bars: (A) 10 mm; (B) 5 mm.
doi:10.1371/journal.pone.0001414.g005
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allow Dnmt2 to interact with genomic DNA under in vivo
conditions.
DISCUSSION
Dnmt2 proteins are highly conserved enzymes that function as
cytosine-5 methyltransferases. Their ability to methylate both
DNA and RNA distinguishes Dnmt2 enzymes from other
cytosine-5 methyltransferases, and might provide a mechanistic
link between RNA and DNA modifications. Proteins belonging to
the Dnmt family of enzymes have traditionally been viewed to
reside in the nucleus. Interestingly, cytoplasmic localization of
Dnmt1 has also been described [22], but the functional
significance of this observation is not understood. While DNA is
concentrated in nuclei, RNA molecules are abundant both in
nuclear and cytoplasmic compartments. Therefore, a cytosine-5
methyltransferase with activity towards both DNA and RNA
substrates could function in any compartment containing nucleic
acids and the specificity to the respective substrate could be
determined by binding partners. Consistent with this notion, our
results show that the localization of Drosophila Dnmt2 is both
cytoplasmic and nuclear and therefore more complex than
previously anticipated [11].
In contrast to previous work, which used either unpurified
antibodies against Dnmt2 peptides [8] or antibodies cross-reacting
with the catalytic motifs of mammalian Dnmt1 [13], we have used
purified antibodies against a Dnmt2-specific peptide to unambig-
uously identify Dnmt2 as a 40 kDa cytoplasmic and nuclear
protein. Both cellular compartments contain Dnmt2 throughout
development. At the tissue level, Dnmt2 is ubiquitously expressed
but is enriched in muscle and gut of the developing embryo, in the
cytoplasm of developing ovarian cysts as well as in proliferating
cells in testes. A tissue-specific expression pattern has also been
observed for zebrafish Dnmt2 [15]. In contrast to zebrafish, the
Drosophila null mutants for Dnmt2 are viable and fertile [11]. The
reasons for this discrepancy are presently unknown.
It has been shown that epitope-tagged human DNMT2 localizes
to the cytoplasm of transiently transfected NIH3T3 cells and this
observation has been interpreted to reflect a general cytoplasmic
localization of Dnmt2 [11]. However, a nuclear or chromatin
localization of Dnmt2-like proteins has been reported in
Dictyostelium [10] and in Entamoeba. In the latter organism,
Dnmt2 has been biochemically associated with the nuclear matrix
[17]. These results suggested that Dnmt2 proteins could interact
directly with DNA. Of note, Dnmt2 contains no nuclear
localization signal but a predicted nuclear export signal (aa 281-
293). This suggests that other pathways are mediating Dnmt2
Figure 6. Nuclear access reporter assay using GAL4:VP16-Dnmt2 fusion proteins. (A) Schematic representation of the nuclear access reporter assay.
Ubiquitous expression of the GAL4:VP16 (GV) fusion proteins (black bar) causes the expression of EGFP only in some cells (green) due to selective
nuclear access of the fusion protein. (B) GV-fusion proteins. GV-Dnmt2 (upper panel), Dnmt2-GV-Dnmt2 fusion expressing GV in the context of a split
Dnmt2 protein (lower panel) which served as control. (C) GAL4:VP16-Dnmt2 expression in third instar larval brains causes widespread UAS-EGFP
expression in the ventral ganglion. The magnification shows that regularly spaced cells (neuroblasts) express EGFP (green). (D) Ubiquitous
GAL4:VP16-Dnmt2 in third instar larval eye discs causes specific UAS-EGFP expression behind the morphogentic furrow (arrow). Magnification of a
field of cells shows robust expression in differentiated photoreceptor cells. (E) The control construct (GAL4:VP16 in a split Dnmt2 protein) causes
background levels of UAS-EGFP expression. GAL4 (gray), EGFP (green), DNA (red). Scale bars: (C) 100 mm; (D, E) 70 mm.
doi:10.1371/journal.pone.0001414.g006
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controlled. In agreement with this notion we found that Dnmt2 is
re-localizing to nuclear structures during specific stages of the cell
cycle.
Our sub-cellular fractionation experiments showed that a
significant amount of nuclear Dnmt2 was insoluble after
micrococcal nuclease digest, DNAse treatment and salt extraction.
This suggested that nuclear Dnmt2 is tightly bound to structures
such as the nuclear matrix. The nuclear matrix as a non-
chromosomal scaffold within the nucleus remains a controversial
concept in cell biology [23] and is poorly defined in terms of
composition and function. Biochemically purified nuclear matrix
material contains proteins, DNA and RNA [24]. Matrix
attachment regions (MARs) in DNA are thought to separate
chromatin into topologically constrained loop domains allowing to
control for the compaction of chromatin as well as for DNA
replication and gene regulation [25,26]. The Entamoeba Dnmt2
homologue binds in vitro to EhMRS2, a DNA element containing
the consensus scaffold/matrix attachment region (S/MAR)
bipartite recognition sequences suggesting that Dnmt2 like
molecules can interact directly with DNA [17]. EhMRS2 contains
internal tandem repeats coding for small RNAs of unknown
function [27]. The association of Dnmt2 with the nuclear matrix
suggests that this cytosine-5 methyltransferase contributes to the
regulatory functions of DNA elements that contain S/MAR
sequences.
Live imaging analysis revealed that Dnmt2-EGFP is ubiqui-
tously localized in the syncitial cytoplasm but condenses around
mitotic chromosomes. This is reminiscent of the mitotic scaffold
proteins Skeletor [28] and Chromator [29]. Similar to Dnmt2,
these proteins form an intranuclear spindle-shaped structure
during prophase that precedes the assembly of the spindle.
Skeletor/Chromator and microtubules display a similar distribu-
tion throughout mitosis, but by telophase, Skeletor/Chromator re-
associate with chromatin while Dnmt2-EGFP localizes to
microtubule structures such as the midbody. Components of the
spindle matrix have been hypothesized to be involved in the
regulation of the nuclear architecture [30] and may provide
structural support for the mitotic spindle [28].
The ability of Dnmt2 to methylate both DNA and tRNA
predicts a complex localization pattern for this class of enzymes.
While DNA methylation would be catalyzed in the nucleus, tRNA
modifications have been shown to occur both in nucleoli and on
the surface of the nuclear envelope in yeast [18]. Also, cytosine-5
methylation of rRNA has been shown to occur in nucleoli [31]. In
agreement with these observations, the vertebrate Misu/NSUN2
protein, a cytosine-5 methyltransferase with catalytic activity
towards DNA, tRNA and rRNA has been shown to localize to the
nucleoplasm and to nucleoli [32,33]. Interestingly, Misu/NSUN2
also localized to mitotic spindles during mitosis [32] and has been
shown to be a substrate of aurora B kinase [33] which is essential
for the segregation of chromosomes and an integral part of the
mitotic passenger complex. It is possible that the mitotic
localization pattern of Dnmt2 reflects the distribution of the
protein into daughter cells via nuclear envelope vesicles [34].
However, the ability of Dnmt2 fusion proteins to access a genomic
reporter construct in mitotic cells argues that the protein might be
able to modify genomic DNA or nuclear RNAs during this stage.
MATERIALS AND METHODS
Fly stocks
The Dnmt2 mutant allele has been described previously [11]. yw
was used as a wild-type strain. Hs-GAL4 [35] or asense GAL4
(provided by Helen Skaer) were used for expression of UAS-
Dnmt2-EGFP transgenes. UAS-EGFP transgenic flies were
provided by Renato Paro, His2A-mRFP1 transgenic flies have
been described previously [36]. Flies were reared on standard
Drosophila medium at 25uC.
DNA constructs
The construct for GAL4-inducible Dnmt2-EGFP expression was
generated by replacing H2B in pH2B-EGFP (a gift from Peter
Becker) with the ORF of Dnmt2. The construct was subsequently
sub-cloned into pUAST [35] or pWR-Ubq [37]. pGeno-Dnmt2-
EGFP was created by replacing the C-terminal half of Dnmt2 in a
genomic Dnmt2 construct with a fragment containing the C-
terminal half of Dnmt2 fused to EGFP from pUAST-Dnmt2-
EGFP. pGeno-Dnmt2-EGFP encompasses 300 bp upstream of
the start and 150 bp downstream of the stop codon of Dnmt2.
This was sub-cloned into pCaSpeR-4. The construct containing
the GAL4:VP16 fusion to Dnmt2 was created by subcloning the
GAL4:VP16 domain from pNT63.10 [21] into a pbGlo2xmyc
vector [38] containing the Dnmt2 cDNA to create an N-terminal
in frame fusion protein of GAL4:VP16 to Dnmt2, followed by sub-
cloning into pWR-Ubq. Constructs were verified by sequencing
and expression analysis. Detailed information will be provided
upon request. Transgenic fly lines were generated by P-element
mediated germ line transformation (Rubin and Spradling, 1982).
Antibodies
Polyclonal antibodies against Dnmt2 peptide epitopes were raised
in rabbits and have been described elsewhere [8]. A Dnmt2
peptide (78CQPHTRQGLQRDTEDK93) was synthesized and
coupled to SulfoLink gel (Pierce), according to the manufacturer’s
instructions. Peptide-specific antibodies were purified using high-
salt conditions and elution in 0.1 M glycine (pH 3.5) followed by
dialysis. Affinity purified Dnmt2 antibody was diluted 1:500 for
Western blots. Other antibodies used in Western blots (WB) or
immunofluorescence (IF) were: armadillo (Hybridoma bank-N2
7A1) 1:100 for IF; a-tubulin (Sigma DM1A), 1:10.000 for WB and
1:200 for IF, lamin C [39], 1:1.000 for WB; EGFP (Abcam-
Ab6556), 1:2.000 for WB and 1:1000 in IF; Prospero (Hybridoma
bank-MR1A) 1:100 for IF; fibrillarin (Abcam-Ab5821), 1:1000 for
WB, Histone 3 (Cell Signaling) 1:10.000 for WB, CP190 [40]
1:500 for WB, GAL4 (Upstate) 1:500 in IF.
Immunofluorescence
Embryo immunostainings were performed essentially as described
[41], with the following modifications. For colcemide and taxol
experiments, 1–3 h old embryos were treated with colcemide
(5 mM) or taxol (25 mM) for 10 minutes before fixation as
described previously [42]. After de-vitellinization in methanol,
embryos were washed in PBS/0.1% Tx-100 and blocked in PBS/
3% normal goat serum/3% BSA/0.1% Tx-100. Larval imaginal
discs and brains were dissected from third instar larvae in PBS,
fixed in 5% PFA, followed by treatment as used in embryo
stainings. For ovary and testis stainings, well-fed adult flies were
dissected in PBS and tissues were transferred into 5% PFA in
buffer B (100 mM KH2PO4/K2HPO4 (pH 6.8), 450 mM KCl,
150 mM NaCl, 20 mM MgCl2) and fixed for 20 minutes at room
temperature (RT), followed by treatment as used in embryo
stainings. Fixed tissue was incubated overnight at 4uC with
primary antibodies followed by incubation with secondary
antibodies. Cy5 anti–mouse (Jackson ImmunoResearch Labora-
tories) were used 1:250 and Alexa 488 anti–rabbit (Molecular
Probes) antibodies were used at 1:500. RNase A was included in
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stain DNA (Gonzalez and Glover, 1993). DNA was stained with
DAPI (1 ng/ml) or propidium iodide (0,5 mg/ml, Molecular
Probes). After mounting in Fluoromount (Biozol), samples were
analyzed by confocal laser scanning microscopy (TCS SP2, Leica
Microsystems, Germany) or Nikon C1Si (Nikon Imaging Facility,
Heidelberg). Images were converted to Photoshop CS format
(Adobe System, Inc.), pseudo-colored and merged.
Protein extraction and immunoprecipitation assay
For cytoplasmic and nuclear protein extracts, embryos were de-
chorionated, snap frozen in liquid N2, homogenized in buffer A
(10 mM Hepes pH 7.9, 10 mM KCl, 1.5 mM MgCl2,1 m M
EDTA, 0.1 mM EGTA, 1 mM DTT, 0.34 M Sucrose, 10% w/v
glycerol, 1 mM PMSF, 16Roche complete proteinase inhibitors).
Larvae (collected according to instar stage) and adult flies
(dissected in PBS) were processed as described for embryonic
tissue. After homogenization using a syringe (25 G), Triton-X-100
was added to 0.1% and proteins were extracted at 4uC for
30 minutes. The homogenate was filtered through gaze and
processed as described previously [43]. For whole cell protein
extracts, tissues were collected, snap frozen in liquid N2 and
homogenized in IP-buffer (25 mM Tris, pH 8.0, 27.5 mM NaCl,
20 mM KCl, 25 mM sucrose, 10 mM EDTA, 10 mM EGTA,
1 mM DTT, 10% (v/v) glycerol, 0.5% Nonidet P40, 1 mM
PMSF, 16 Roche complete proteinase inhibitors). To obtain
soluble protein, extracts were spun at 16.000 g for 30 minutes at
4uC. For immunoprecipitation experiments, Protein A beads (GE
Healthcare) were incubated with 3 mg anti-Dnmt2 antibodies and
1 mg/ml insulin (Sigma) for 1 hour at 4uC, washed 365 minutes
in IP-buffer before whole cell protein extracts were added to the
beads for 3 hours at 4uC. Peptide block was added in parallel at a
concentration of 150 ng/ml to control for specificity of the IP-
reaction. Beads were collected by centrifugation and washed 4
times 10 minutes at 4uC with IP-buffer, followed by 4 minutes at
94uC in SDS-sample buffer and Western analysis.
Sub-cellular fractionation
Tissue was homogenized in hypotonic buffer A (10 mM Hepes
pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 1 mM
DTT, 1 mM PMSF, 16 Roche complete proteinase inhibitors).
Lysed extracts were cleared of debris by low speed centrifugation
at 400 g for 10 min at 4uC. Supernatants were spun at 1.700 g for
10 min 4uC to obtain crude nuclei. Crude nuclei were
resuspended in buffer A and spun through a sucrose cushion
containing 15 mM Tris pH 7.5, 60 mM KCl, 15 mM NaCl,
5 mM MgCl2, 1 M sucrose, 0.5 mM DTT, 1 mM PMSF, 16
Roche complete proteinase inhibitors) at 16.000 g for 30 minutes
at 4uC. For whole nuclear protein extraction, nuclei were
homogenized in urea extraction buffer (10 mM Tris pH 8,
100 mM NaH2PO4, 8 M urea) for 10 minutes at room temper-
ature (RT), spun at 16.000 g for 10 minutes at RT and analyzed
by Western blot. Nucleoli isolation was performed as described
previously [44]. For nucleosomal extraction, purified nuclei were
resupended in buffer A containing 1 mM CaCl2, diluted to a
concentration of 200 mg/ml chromatin. MNase was added to
10 U/50 mg chromatin, incubated for 8 min at 37uC and stopped
by addition of EDTA to 10 mM. Nuclei were pelleted and
resuspended in 0.2 mM ice-cold EDTA, pH 7.0 for 1 hour (this
hypotonic treatment forces nucleosomes into the supernatant).
Remaining chromatin was pelleted by centrifugation and
supernatant and nuclear pellet subjected to SDS-PAGE. For
nuclear matrix extraction, purified nuclei were resupended in
cytoskeletal buffer (CSK-buffer: 10 mM Pipes, pH 6.8, 100 mM
NaCl, 300 mM sucrose, 3 mM MgCl2, 1 mM EGTA, 16Roche
complete proteinase inhibitors, 1 mM PMSF, 1 mM DTT, and
0.5% Triton X-100. Chromatin was solubilized by DNA digestion
with 1 mg/ml of RNase-free DNAase I in CSK buffer plus
proteinase inhibitors for 15 minutes at 37uC. Ammonium sulphate
was added to 0.25 M and, after 5 minutes at 4uC, samples were
centrifuged. The pellet was further extracted with 2 M NaCl in
CSK buffer for 5 minutes at 4uC. The remaining pellet was
solubilized in urea extraction buffer (see above) and was
considered the nuclear matrix-containing fraction.
Live imaging analysis
Staged collections were de-chorionated, thoroughly washed,
aligned on a cover slip and overlaid with voltalef 10 S oil. For
time-lapse analysis, images were acquired with a confocal laser
scanning microscopy (TCS SP2, Leica Microsystems, Germany)
using the 488 and 561 nm laser lines at low power (1–5%).
Recording was carried out at 1 minute intervals and data was
analyzed using ImageJ software.
SUPPORTING INFORMATION
Figure S1 Overexpression of EGFP does not lead to mitotic
accumulation of EGFP. (A) Actin5C-GAL4 driven UAS-EGFP
expression in the embryonic neuroectoderm shows no signs of a
mitotic accumulation of EGFP at chromatin (prophase-upper
panel, metaphase-lower panel). Scale bar: as in Fig. 4B
Found at: doi:10.1371/journal.pone.0001414.s001 (0.76 MB TIF)
Movie S1 Live imaging of nuclear division cycles 10-11 of an
embryo expressing pUbq-Dnmt2-EGFP and His2Av-mRFP1.
Embryos were mounted on an open coverslip and viewed by dual
wavelength time-lapse LSCM. Frames were recorded in 1 min
intervals and images were merged with Dnmt2-EGFP in green
and His2A-mRFP1 in red. Scale: as in Fig. 5A
Found at: doi:10.1371/journal.pone.0001414.s002 (1.83 MB
MPG)
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